ロード中...
Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients
Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...
保存先:
| 出版年: | Front Neurol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7652845/ https://ncbi.nlm.nih.gov/pubmed/33193063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.594152 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|